IMFINZITM (durvalumab) has received approval in the European Union as a monotherapy for treating adults with limited-stage ...

Approval based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo ...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...

European Commission approves Bristol Myers Squibb’s Opdivo plus Yervoy for first-line treatment of adult patients with unresectable or advanced HCC: Princeton, New Jersey Monday ...

A novel strategy using lipid nanoparticles to reprogram liver immunity shows promise in generating antitumor responses ...

Taking a popular and cheap over-the-counter pill could prevent certain forms of cancer from spreading to other areas like the liver and lungs, a team from Cambridge University found.

All DCs express the surface markers CD11c, CD45, MHC II and CD135. The cDC2 subset is CD4 + and expresses CD11b, CD80, CD86 and CD40 but do not express CD8 and CD205 otherwise expressed by cDC1.

This study used Wistar rats (7 weeks of age; 222 ± 10 g; half male and half female) at the beginning of the study. The rats were acclimatized for 10 days before the experiment, and they were kept in ...

Natural killer (NK) cells, originally so named because they have the capacity to kill other cells without activation, can be licensed and educated to regulate tissue homeostasis. This notion has ...

After hours: March 19 at 7:44:25 PM EDT Loading Chart for BCTX ...